Market Tracker

05/03 4:09pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

33.55
Delayed Data
As of 3:54pm ET
 +0.415 / +1.25%
Today’s Change
29.66
Today|||52-Week Range
51.42
-21.55%
Year-to-Date

Today’s Trading

Previous close33.13
Today’s open32.77
Day’s range32.55 - 34.53
Volume383,970
Average volume (3 months)689,470
Market cap$2.4B
Dividend yield--
Data as of 3:54pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+21.33%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+44.36%
P/E ratio62.0
Price/Sales3.58
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.08-0.52%
MDCOMedicines Co+0.54+1.52%
LGNDLigand Pharmaceutica...-3.01-2.45%
MYGNMyriad Genetics Inc-0.49-1.34%
Data as of 3:54pm ET, 05/03/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts